Last edition
News about "Sharon Barr"
AstraZeneca's Tozorakimab Hits Key Phase 3 Goal in COPD Trial
AstraZeneca reports positive Phase III MIRANDA trial results for tozorakimab in COPD, marking its third successful pivotal study and reinforcing the potential of its IL-33-targeting biologic to transform respiratory care.
Sharon Barr | 21/04/2026 | By News Bureau
AstraZeneca Boosts Weight Management Portfolio via CSPC Collaboration
Under this agreement, Astrazeneca and CSPC Pharmaceuticals will initially progress four programmes, which utilise CSPC's advanced Artificial Intelligence (AI)-driven peptide drug discovery platform and their proprietary LiquidGel once-monthly dosing platform technology.
Sharon Barr | 31/01/2026 | By News Bureau | 203
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy